Share on StockTwits

Analysts at Investec increased their price target on shares of Synergy Healthcare plc (LON:SYR) from GBX 1,565 ($26.25) to GBX 1,607 ($26.96) in a research report issued to clients and investors on Thursday. The firm currently has a “buy” rating on the stock. Investec’s price objective suggests a potential upside of 13.81% from the stock’s previous close.

Shares of Synergy Healthcare plc (LON:SYR) opened at 1435.00 on Thursday. Synergy Healthcare plc has a 1-year low of GBX 991.00 and a 1-year high of GBX 1465.00. The stock’s 50-day moving average is GBX 1392. and its 200-day moving average is GBX 1331.31. The company’s market cap is £845.2 million.

A number of other analysts have also recently weighed in on SYR. Analysts at N+1 Singer raised their price target on shares of Synergy Healthcare plc from GBX 1,258 ($21.10) to GBX 1,283 ($21.52) in a research note on Thursday, July 31st. They now have a “hold” rating on the stock. Separately, analysts at Canaccord Genuity reiterated a “sell” rating on shares of Synergy Healthcare plc in a research note on Wednesday, July 23rd. They now have a GBX 1,218 ($20.43) price target on the stock. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of GBX 1,305.50 ($21.90).

Synergy Health plc and its subsidiaries deliver a range of specialist outsourced services to healthcare providers and other customers concerned with health management.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.